{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:27:32Z","timestamp":1791120452553,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,8,2]],"date-time":"2007-08-02T00:00:00Z","timestamp":1186012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,8,2]],"date-time":"2007-08-02T00:00:00Z","timestamp":1186012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1038\/sj.leu.2404892","type":"journal-article","created":{"date-parts":[[2007,8,2]],"date-time":"2007-08-02T09:04:13Z","timestamp":1186045453000},"page":"2145-2152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":177,"title":["Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"21","author":[{"given":"B N","family":"Savani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Rezvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A S M","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Zeilah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kurlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Hensel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,2]]},"reference":[{"key":"BF2404892_CR1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","volume":"94","author":"L Ruggeri","year":"1999","unstructured":"Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94: 333\u2013339.","journal-title":"Blood"},{"key":"BF2404892_CR2","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","volume":"295","author":"L Ruggeri","year":"2002","unstructured":"Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097\u20132100.","journal-title":"Science"},{"key":"BF2404892_CR3","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1182\/blood-2005-05-1897","volume":"107","author":"BN Savani","year":"2006","unstructured":"Savani BN, Rezvani K, Mielke S, Montero A, Kurlander R, Carter CS et al. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood 2006; 107: 1688\u20131695.","journal-title":"Blood"},{"key":"BF2404892_CR4","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1097\/00007890-199506270-00016","volume":"59","author":"M Zeis","year":"1995","unstructured":"Zeis M, Uharek L, Glass B, Gaska T, Steinmann J, Gassmann W et al. Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice. Transplantation 1995; 59: 1734\u20131736.","journal-title":"Transplantation"},{"key":"BF2404892_CR5","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1182\/blood.V75.11.2250.2250","volume":"75","author":"M Hauch","year":"1990","unstructured":"Hauch M, Gazzola MV, Small T, Bordignon C, Barnett L, Cunningham I et al. Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia. Blood 1990; 75: 2250\u20132262.","journal-title":"Blood"},{"key":"BF2404892_CR6","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/jnci\/85.18.1475","volume":"85","author":"WJ Murphy","year":"1993","unstructured":"Murphy WJ, Reynolds CW, Tiberghien P, Longo DL . Natural killer cells and bone marrow transplantation. J Natl Cancer Inst 1993; 85: 1475\u20131482.","journal-title":"J Natl Cancer Inst"},{"key":"BF2404892_CR7","first-page":"433","volume":"2","author":"AG Brooks","year":"2000","unstructured":"Brooks AG, Boyington JC, Sun PD . Natural killer cell recognition of HLA class I molecules. Rev Immunogenet 2000; 2: 433\u2013448.","journal-title":"Rev Immunogenet"},{"key":"BF2404892_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/35014520","volume":"405","author":"JC Boyington","year":"2000","unstructured":"Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD . Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 2000; 405: 537\u2013543.","journal-title":"Nature"},{"key":"BF2404892_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/14653240601078721","volume":"8","author":"L Ruggeri","year":"2006","unstructured":"Ruggeri L, Mancusi A, Burchielli E, Aversa F, Martelli MF, Velardi A . Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. Cytotherapy 2006; 8: 554\u2013558.","journal-title":"Cytotherapy"},{"key":"BF2404892_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002770050246","volume":"74","author":"YZ Jiang","year":"1997","unstructured":"Jiang YZ, Barrett AJ, Goldman JM, Mavroudis DA . Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation. Ann Hematol 1997; 74: 1\u20136.","journal-title":"Ann Hematol"},{"key":"BF2404892_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1365-2141.1991.tb07949.x","volume":"77","author":"S Mackinnon","year":"1991","unstructured":"Mackinnon S, Bungey J, Chase A, Paulsen W, Hows JM, Goldman JM . Origin and function of adherent lymphokine activated killer cells in patients with chronic myeloid leukaemia who relapse following bone marrow transplantation. Br J Haematol 1991; 77: 60\u201365.","journal-title":"Br J Haematol"},{"key":"BF2404892_CR12","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1182\/blood-2005-02-0479","volume":"106","author":"G Sconocchia","year":"2005","unstructured":"Sconocchia G, Lau M, Provenzano M, Rezvani K, Wongsena W, Fujiwara H et al. The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions. Blood 2005; 106: 3666\u20133672.","journal-title":"Blood"},{"key":"BF2404892_CR13","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/sj.leu.2404300","volume":"20","author":"G Sconocchia","year":"2006","unstructured":"Sconocchia G, del PD, Barrett AJ . Non-classical antileukemia activity of early recovering NK cells after induction chemotherapy and HLA-identical stem cell transplantation in myeloid leukemias. Leukemia 2006; 20: 1632\u20131633.","journal-title":"Leukemia"},{"key":"BF2404892_CR14","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1182\/blood-2003-02-0438","volume":"103","author":"MA Cook","year":"2004","unstructured":"Cook MA, Milligan DW, Fegan CD, Darbyshire PJ, Mahendra P, Craddock CF et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004; 103: 1521\u20131526.","journal-title":"Blood"},{"key":"BF2404892_CR15","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","volume":"105","author":"KC Hsu","year":"2005","unstructured":"Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 2005; 105: 4878\u20134884.","journal-title":"Blood"},{"key":"BF2404892_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1399-0039.2005.00396.x","volume":"65","author":"SD De","year":"2005","unstructured":"De SD, Bishara A, Witt CS, Nagler A, Brautbar C, Slavin S et al. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens 2005; 65: 519\u2013528.","journal-title":"Tissue Antigens"},{"key":"BF2404892_CR17","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.4049\/jimmunol.174.10.6540","volume":"174","author":"W Leung","year":"2005","unstructured":"Leung W, Iyengar R, Triplett B, Turner V, Behm FG, Holladay MS et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 2005; 174: 6540\u20136545.","journal-title":"J Immunol"},{"key":"BF2404892_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.0001-2815.2004.00182.x","volume":"63","author":"A Bishara","year":"2004","unstructured":"Bishara A, De SD, Witt CC, Brautbar C, Christiansen FT, Or R et al. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens 2004; 63: 204\u2013211.","journal-title":"Tissue Antigens"},{"key":"BF2404892_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.bmt.1705468","volume":"38","author":"C Chen","year":"2006","unstructured":"Chen C, Busson M, Rocha V, Appert ML, Lepage V, Dulphy N et al. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant 2006; 38: 437\u2013444.","journal-title":"Bone Marrow Transplant"},{"key":"BF2404892_CR20","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/sj.leu.2403839","volume":"19","author":"S Verheyden","year":"2005","unstructured":"Verheyden S, Schots R, Duquet W, Demanet C . A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia 2005; 19: 1446\u20131451.","journal-title":"Leukemia"},{"key":"BF2404892_CR21","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.bbmt.2006.08.034","volume":"12","author":"A Montero","year":"2006","unstructured":"Montero A, Savani BN, Shenoy A, Read EJ, Carter CS, Leitman SF et al. T cell depleted peripheral blood stem cell allotransplantation with T cell add back for patients with hematological malignancies: effect of chronic GVHD on outcome. Biol Blood Marrow Transplant 2006; 12: 1318\u20131325.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF2404892_CR22","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.coi.2004.07.013","volume":"16","author":"B Dupont","year":"2004","unstructured":"Dupont B, Hsu KC . Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation. Curr Opin Immunol 2004; 16: 634\u2013643.","journal-title":"Curr Opin Immunol"},{"key":"BF2404892_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0198-8859(02)00373-7","volume":"63","author":"K Gagne","year":"2002","unstructured":"Gagne K, Brizard G, Gueglio B, Milpied N, Herry P, Bonneville F et al. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol 2002; 63: 271\u2013280.","journal-title":"Hum Immunol"},{"key":"BF2404892_CR24","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1097\/00007890-199912150-00024","volume":"68","author":"CS Witt","year":"1999","unstructured":"Witt CS, Dewing C, Sayer DC, Uhrberg M, Parham P, Christiansen FT . Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation 1999; 68: 1784\u20131789.","journal-title":"Transplantation"},{"key":"BF2404892_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1034\/j.1399-0039.2000.560403.x","volume":"56","author":"KA Crum","year":"2000","unstructured":"Crum KA, Logue SE, Curran MD, Middleton D . Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. Tissue Antigens 2000; 56: 313\u2013326.","journal-title":"Tissue Antigens"},{"key":"BF2404892_CR26","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1182\/blood-2005-04-1644","volume":"106","author":"S Cooley","year":"2005","unstructured":"Cooley S, McCullar V, Wangen R, Bergemann TL, Spellman S, Weisdorf DJ et al. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood 2005; 106: 4370\u20134376.","journal-title":"Blood"},{"key":"BF2404892_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbmt.2006.09.009","volume":"13","author":"JY Sun","year":"2007","unstructured":"Sun JY, Dagis A, Gaidulis L, Miller MM, Rodriguez R, Parker P et al. Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patients. Biol Blood Marrow Transplant 2007; 13: 197\u2013205.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF2404892_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.bbmt.2006.10.029","volume":"13","author":"AK Singh","year":"2007","unstructured":"Singh AK, Savani BN, Albert PS, Barrett AJ . Efficacy of CD34+ stem cell dose in patients undergoing allogeneic peripheral blood stem cell transplantation after total body irradiation. Biol Blood Marrow Transplant 2007; 13: 339\u2013344.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF2404892_CR29","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1046\/j.1365-2141.2003.04364.x","volume":"121","author":"O Ringden","year":"2003","unstructured":"Ringden O, Barrett AJ, Zhang MJ, Loberiza FR, Bolwell BJ, Cairo MS et al. Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. Br J Haematol 2003; 121: 874\u2013885.","journal-title":"Br J Haematol"},{"key":"BF2404892_CR30","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1046\/j.1440-1711.1999.00865.x","volume":"77","author":"HS Warren","year":"1999","unstructured":"Warren HS . Using carboxyfluorescein diacetate succinimidyl ester to monitor human NK cell division: analysis of the effect of activating and inhibitory class I MHC receptors. Immunol Cell Biol 1999; 77: 544\u2013551.","journal-title":"Immunol Cell Biol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404892.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404892","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404892.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:48:49Z","timestamp":1648766929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,2]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["BF2404892"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404892","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,2]]},"assertion":[{"value":"14 May 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}